Fingerprint
Dive into the research topics of 'A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically